April 19, 2023

From the Co-Chairs, April 2023

The ComboMATCH registration trial opens; NCI creates Clinical Trials Innovation unit, unveils revised National Cancer Plan
April 19, 2023

Now Enrolling: ECOG-ACRIN Opens the ComboMATCH Patient Registration Trial as the Gateway to a Coordinated Set of Treatment Trials

ComboMATCH researchers are discovering new drug combinations that show promise for patients with advanced cancers, based on strong pre-clinical in vivo evidence of therapeutic effectiveness
April 19, 2023

Trial Spotlight: Kim Reiss on the EA2192/APOLLO Study for Certain Patients with Pancreatic Cancer

This phase 2 study is exploring whether the addition of maintenance PARP inhibition for BRCA- or PALB2-mutated pancreatic cancer improves outcomes
April 19, 2023

Institution Spotlight: Main Line Health and Lankenau Institute for Medical Research

A member of ECOG-ACRIN since 1973
April 19, 2023

Trial Results: ECOG-ACRIN Research Round-Up

Summaries of recently published ECOG-ACRIN research results
April 19, 2023

News in Brief, April 2023

Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more